MEDIGUS (Israel) Performance

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>MDG</div>
MDGS -- Israel Stock  

ILA 30.90  0.10  0.32%

The company secures Beta (Market Risk) of 0.3832 which conveys that as returns on market increase, MEDIGUS returns are expected to increase less than the market. However during bear market, the loss on holding MEDIGUS will be expected to be smaller as well. Even though it is essential to pay attention to MEDIGUS price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis approach towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. MEDIGUS exposes twenty-one different technical indicators which can help you to evaluate its performance. MEDIGUS has expected return of -0.1892%. Please be advised to verify MEDIGUS Coefficient Of Variation, Variance and the relationship between Downside Deviation and Standard Deviation to decide if MEDIGUS past performance will be repeated in the future.
00

Risk-Adjusted Performance

Over the last 30 days MEDIGUS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Quick Ratio5.43
Fifty Two Week Low28.90
Target High Price1.50
Fifty Two Week High67.00
Target Low Price1.50
Horizon     30 Days    Login   to change

MEDIGUS Relative Risk vs. Return Landscape

If you would invest  3,390  in MEDIGUS on December 29, 2019 and sell it today you would lose (300.00)  from holding MEDIGUS or give up 8.85% of portfolio value over 30 days. MEDIGUS is generating negative expected returns and assumes 3.3614% volatility on return distribution over the 30 days horizon. Simply put, 30% of equities are less volatile than MEDIGUS and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
    
  Risk (%) 
Assuming 30 trading days horizon, MEDIGUS is expected to under-perform the market. In addition to that, the company is 6.34 times more volatile than its market benchmark. It trades about -0.06 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.17 per unit of volatility.

MEDIGUS Market Risk Analysis

Sharpe Ratio = -0.0563
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsMDGS

MEDIGUS Relative Performance Indicators

Estimated Market Risk
 3.36
  actual daily
 
 30 %
of total potential
 
3030
Expected Return
 -0.19
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.06
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average MEDIGUS is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDIGUS by adding it to a well-diversified portfolio.

MEDIGUS Alerts

Equity Alerts and Improvement Suggestions

MEDIGUS is not yet fully synchronised with the market data
MEDIGUS generates negative expected return over the last 30 days
MEDIGUS has high historical volatility and very poor performance
MEDIGUS has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 459 K. Net Loss for the year was (6.17 M) with loss before overhead, payroll, taxes, and interest of (171 K).
MEDIGUS has accumulated about 8.79 M in cash with (3.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Additionally see Stocks Correlation. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Company logos by clearbit